Document is current
Any future updates will be listed below
-
Authors
Sjúrðarson, Tórur
Kristiansen, Jacobina
Nordsborg, Nikolai B.
Gregersen, Noomi O.
Lydersen, Leivur N.
Grove, Erik L.
Kristensen, Steen D.
Hvas, Anne-Mette
Mohr, Magni
-
Funding
Funding for this research was provided by:
Granskingarráðið (0352)
National Hospital of the Faroe Islands
- License Information
-
More Information
Article History
Received: 12 January 2023
Accepted: 20 October 2023
First Online: 25 October 2023
Competing interests
: The authors report the following general conflicts. E.L.G. has no conflicts related to the present study but has received speaker honoraria or consultancy fees from AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Pfizer, MSD, Novo Nordisk, Lundbeck Pharma and Organon. He is serving as investigator in clinical studies sponsored by AstraZeneca, Idorsia, and Bayer and has received unrestricted research grants from Boehringer Ingelheim. T.S., J.K., N.B.N., N.O.G., L.N.L., S.D.K., A.M.H., and M.M. have no competing interests to declare.
